Stocktoria
Tilray Brands, Inc. TLRY
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2018-07-19
Tilray Brands, Inc. financials (annual)
Bars are annual figures from 2018 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $915.5M | $821.3M | $788.9M | $627.1M | $628.4M | $513.1M | $210.5M | $405.3M | $167.0M | $43.1M |
| Gross profit | $260.4M | $240.6M | $223.4M | $147.0M | $116.8M | $123.2M | $24.7M | $96.1M | -$23.5M | $14.3M |
| R&D expense | $361,000 | $284,000 | $635,000 | $682,000 | $1.5M | $830,000 | $4.4M | $1.9M | $9.2M | $5.9M |
| Operating income | -$63.0M | -$2.3B | -$174.7M | -$1.4B | -$610.4M | -$132.2M | -$201.1M | -$104.0M | -$304.1M | -$57.8M |
| Interest expense | $29.9M | $41.3M | $49.3M | $46.6M | $39.7M | $30.9M | — | $25.6M | — | — |
| Income tax | $17.1M | -$121.0M | -$26.6M | -$7.2M | -$6.5M | -$9.0M | -$5.6M | -$8.4M | -$8.4M | -$4.5M |
| Net income | -$121.4M | -$2.2B | -$245.0M | -$1.5B | -$476.8M | -$367.4M | -$271.1M | -$102.5M | -$321.2M | -$67.7M |
| EPS (diluted) | $-1.09 | $-24.56 | $-3.30 | $-2.35 | $-0.99 | $-1.36 | — | $-0.47 | — | — |
| Operating cash flow | -$69.1M | -$94.6M | -$30.9M | $7.9M | -$177.3M | -$44.7M | -$129.4M | -$100.6M | -$258.1M | -$46.2M |
| Free cash flow | — | — | — | — | — | — | -$174.0M | — | -$331.8M | -$96.4M |
| Cash & equivalents | $226.0M | $221.7M | $228.3M | $206.6M | $415.9M | $488.5M | $189.7M | $360.6M | $96.8M | $487.3M |
| Inventory | $301.2M | $270.9M | $252.1M | $200.6M | $245.5M | $256.4M | $93.6M | $139.8M | $87.9M | $16.2M |
| Total assets | $2.3B | $2.1B | $4.2B | $4.3B | $5.4B | $6.0B | $945.9M | $1.7B | $896.3M | $656.7M |
| Total liabilities | $733.1M | $584.8M | $778.5M | $977.3M | $1.0B | $1.6B | $572.0M | $463.0M | $611.1M | $459.0M |
| Shareholders' equity | $1.6B | $1.5B | $3.4B | $3.3B | $4.4B | $4.5B | $373.9M | $1.3B | $285.3M | $197.7M |
Growth · year-over-year · Revenue CAGR 40.4%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +11.5% | +4.1% | +25.8% | -0.2% | +22.5% | +143.8% | -48.1% | +142.7% | +287.2% | +110.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-05-31. Facts plus Stocktoria's own computed scores — not investment advice.